Gad Avshalomov, MD
Allergy & Immunology · Brooklyn, NYNPI 1609851617
Payments from drug & device makers
Across 284 payments — averaging $157.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Consortium Of Independent Immunology Clinics, LLC$39K
- GSK$1K
- Pfizer$840
- Genentech USA, Inc.$643
- Novartis$491
- AstraZeneca$385
- plus $2K from 22 others
Across 67 payments — averaging $908.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ADMA Biomanufacturing LLC$61K
What the payments were for
- Consulting fees$5,02047%
- Food & beverage$5,58053%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Consortium Of Independent Immunology Clinics, LLC | 3 | $39,238 |
| GSK | 57 | $1,067 |
| Pfizer | 43 | $840 |
| Genentech USA, Inc. | 39 | $643 |
| Novartis | 24 | $491 |
| AstraZeneca | 20 | $385 |
| Pharming Healthcare, Inc. | 13 | $327 |
| Amgen | 13 | $272 |
| Sanofi | 11 | $224 |
| Octapharma USA, Inc. | 11 | $208 |
| CSL Behring | 4 | $194 |
| Grifols USA, LLC | 7 | $163 |
| Optinose US, Inc. | 7 | $147 |
| Merck | 8 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $71 |
| Hikma Pharmaceuticals USA | 3 | $63 |
| Biocryst US Sales Co., LLC | 3 | $54 |
| Philips North America LLC | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Covis Pharma GmbH | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Medtronic | 1 | $29 |
| Shire North American Group Inc | 1 | $24 |
| GC Biopharma USA, Inc. | 1 | $23 |
| Incyte Corporation | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| ADMA Biomanufacturing LLC | 1 | $20 |
| Tersera Therapeutics LLC | 1 | $20 |
How this compares
$44,864 in reported general payments places this provider in the 80th percentile of 320 allergy & immunology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 13 | $73,775 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 51 | $33,680 |
| Epinephrine | 141 | $26,460 |
| Breo ElliptaFluticasone/Vilanterol | 58 | $22,351 |
| Arnuity ElliptaFluticasone Furoate | 58 | $18,549 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $13,757 |
| SymbicortBudesonide/Formoterol Fumarate | 50 | $11,339 |
| DuleraMometasone/Formoterol | 26 | $10,889 |
| Spiriva RespimatTiotropium Bromide | 15 | $9,388 |
| Qvar RedihalerBeclomethasone Dipropionate | 20 | $6,629 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 28 | $4,964 |
| Fluticasone Propionate HfaFluticasone Propionate | 17 | $4,055 |
| RyaltrisOlopatadine Hcl/Mometasone | 13 | $4,020 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 156 | $3,738 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 13 | $1,719 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Arnuity Ellipta, Trelegy Ellipta | $1,067 | $54,657139 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $385 | $45,020101 claims |
| Hikma Pharmaceuticals USAEpinephrine, Ryaltris | $63 | $30,480154 claims |
| MerckDulera | $134 | $10,88926 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $44 | $6,62920 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 320 allergy & immunology providers in New York.
Other allergy & immunology in Brooklyn
- Payel GuptaBrooklyn$256K
- Bernard SilvermanBrooklyn$174K
- Rauno JoksBrooklyn$171K
- Jenny ShliozbergBrooklyn$164K
- Dina LibermanBrooklyn$34K
- Peter DeaneRochester$3.7M
- Syed MustafaRochester$3.6M
- Golda HudesBronx$2.4M
- Arye RubinsteinBronx$1.1M
- Ujwala KazaNew York$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.